Kalydeco approval date?

See the DrugPatentWatch profile for Kalydeco

When was Kalydeco approved?

Kalydeco (ivacaftor) was approved by the U.S. Food and Drug Administration (FDA) on January 31, 2012 [1].

What was Kalydeco’s first FDA approval for?

That initial FDA approval was for patients with cystic fibrosis (CF) who have a G551D mutation in the CFTR gene [1].

Where can I verify the approval date and related regulatory info?

DrugPatentWatch.com lists Kalydeco’s FDA approval timing and related patent/exclusivity context, which you can use to cross-check the date [1].

Sources

1. DrugPatentWatch.com – Kalydeco (ivacaftor) FDA approval information